×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NBP – novabridge biosciences - american depositary shares (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NBP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/19
07:00 am
nbp
NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform
Low
Report
NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform
2/17
04:05 pm
nbp
NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immunochemotherapy in Patients with 1L Metastatic Gastric Cancer
Low
Report
NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immunochemotherapy in Patients with 1L Metastatic Gastric Cancer
2/6
06:45 pm
nbp
I-Mab (NASDAQ:NBP) is now covered by analysts at Weiss Ratings. They set a "sell (d-)" rating on the stock.
Medium
Report
I-Mab (NASDAQ:NBP) is now covered by analysts at Weiss Ratings. They set a "sell (d-)" rating on the stock.
2/6
08:03 am
nbp
I-Mab (NASDAQ:NBP) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $9.00 price target on the stock.
Medium
Report
I-Mab (NASDAQ:NBP) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $9.00 price target on the stock.
1/20
07:00 am
nbp
NovaBridge Announces Open Market Purchases by Executive Chairman, Fu Wei
Medium
Report
NovaBridge Announces Open Market Purchases by Executive Chairman, Fu Wei
1/13
05:31 pm
nbp
Macrophage Activation Syndrome Market in the 6MM to Witness Upsurge in Growth at a CAGR of 24.7% During the Forecast Period (2025-2034) | DelveInsight
Low
Report
Macrophage Activation Syndrome Market in the 6MM to Witness Upsurge in Growth at a CAGR of 24.7% During the Forecast Period (2025-2034) | DelveInsight
1/13
05:31 pm
nbp
Macrophage Activation Syndrome Market in the 6MM to Witness Upsurge in Growth at a CAGR of 24.7% During the Forecast Period (2025-2034) | DelveInsight
Low
Report
Macrophage Activation Syndrome Market in the 6MM to Witness Upsurge in Growth at a CAGR of 24.7% During the Forecast Period (2025-2034) | DelveInsight
1/8
07:30 am
nbp
Alveus Therapeutics Launches with $160 Million Series A Financing to Advance Next-Generation Therapies for Obesity and Metabolic Diseases
Medium
Report
Alveus Therapeutics Launches with $160 Million Series A Financing to Advance Next-Generation Therapies for Obesity and Metabolic Diseases
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/19
07:05 am
nbp
Form 6-K NovaBridge Biosciences For: Feb 19
Low
Report
Form 6-K NovaBridge Biosciences For: Feb 19
2/17
04:05 pm
nbp
Form 6-K NovaBridge Biosciences For: Feb 17
Low
Report
Form 6-K NovaBridge Biosciences For: Feb 17
2/6
04:08 pm
nbp
Form 6-K/A NovaBridge Biosciences For: Feb 06
Medium
Report
Form 6-K/A NovaBridge Biosciences For: Feb 06
2/6
08:30 am
nbp
Form 6-K NovaBridge Biosciences For: Feb 06
Medium
Report
Form 6-K NovaBridge Biosciences For: Feb 06
2/3
04:13 pm
nbp
Form SCHEDULE 13D/A NovaBridge Biosciences Filed by: CBC Investment I-Mab Ltd
Low
Report
Form SCHEDULE 13D/A NovaBridge Biosciences Filed by: CBC Investment I-Mab Ltd
1/22
04:05 pm
nbp
Form 6-K NovaBridge Biosciences For: Jan 22
Low
Report
Form 6-K NovaBridge Biosciences For: Jan 22
1/22
07:00 am
nbp
Form 6-K NovaBridge Biosciences For: Jan 22
Low
Report
Form 6-K NovaBridge Biosciences For: Jan 22
1/16
04:05 pm
nbp
Form 6-K NovaBridge Biosciences For: Jan 16
Medium
Report
Form 6-K NovaBridge Biosciences For: Jan 16
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: